English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 25, 2026

LB Pharma navigates tough markets for successful IPO after promising schizophrenia drug data
+ Pharmaceuticals
Patient Daily | Feb 25, 2026

FARE receives $2.5 million from National Peanut Board for food allergy research
+ Regulatory
Patient Daily | Feb 25, 2026

BlackDoctor.org calls for reforms to federal 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Feb 25, 2026

Creative financing models emerge as key support for rare disease drug development
+ Pharmaceuticals
Patient Daily | Feb 25, 2026

How artificial food dyes may affect children's behavior
+ Regulatory
C.D. Marsden | Feb 24, 2026

American Association of Nurse Practitioners President: Federal loan proposal could worsen healthcare workforce shortage
+ Pharmaceuticals
Patient Daily | Feb 24, 2026

FDA maintains support for mRNA vaccine development without public funding
+ Pharmaceuticals
Patient Daily | Feb 24, 2026

Study shows lower costs and fewer follow-ups with telemedicine compared to office visits

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns